Korean Drug Co., Ltd. (KOSDAQ: 014570)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,840.00
-20.00 (-0.41%)
Dec 19, 2024, 9:00 AM KST

Korean Drug Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
51,61478,34885,44197,444112,39478,457
Upgrade
Market Cap Growth
-23.28%-8.30%-12.32%-13.30%43.25%-0.42%
Upgrade
Enterprise Value
31,56041,60553,95071,74992,54867,689
Upgrade
Last Close Price
4730.007180.007664.818545.909669.116649.86
Upgrade
PE Ratio
--7.2410.7815.2720.14
Upgrade
PS Ratio
0.680.961.071.311.681.41
Upgrade
PB Ratio
0.641.021.011.271.591.21
Upgrade
P/TBV Ratio
0.681.021.011.271.601.22
Upgrade
P/FCF Ratio
---12.729.7024.86
Upgrade
P/OCF Ratio
--14.4511.079.1212.64
Upgrade
EV/Sales Ratio
0.420.510.670.961.391.22
Upgrade
EV/EBITDA Ratio
13.724.913.435.637.4714.71
Upgrade
EV/EBIT Ratio
127.686.193.776.378.3819.81
Upgrade
EV/FCF Ratio
-2.12--9.377.9821.45
Upgrade
Debt / Equity Ratio
0.000.000.000.000.000.00
Upgrade
Debt / EBITDA Ratio
0.030.010.010.000.000.02
Upgrade
Debt / FCF Ratio
---0.010.000.03
Upgrade
Asset Turnover
0.730.880.870.870.840.75
Upgrade
Inventory Turnover
1.952.743.413.673.373.23
Upgrade
Quick Ratio
4.564.527.815.515.134.62
Upgrade
Current Ratio
6.876.419.806.826.446.15
Upgrade
Return on Equity (ROE)
-0.48%-6.08%14.63%12.26%10.83%6.09%
Upgrade
Return on Assets (ROA)
0.15%4.56%9.78%8.19%8.67%2.87%
Upgrade
Return on Capital (ROIC)
0.19%5.19%11.09%9.54%10.14%3.34%
Upgrade
Earnings Yield
-0.77%-6.28%13.82%9.28%6.55%4.96%
Upgrade
FCF Yield
-28.86%-9.97%-0.21%7.86%10.31%4.02%
Upgrade
Payout Ratio
0.00%-15.52%18.07%14.80%27.99%
Upgrade
Buyback Yield / Dilution
0.75%0.01%1.25%-0.46%0.37%0.07%
Upgrade
Total Shareholder Return
3.92%0.01%1.25%-0.46%0.37%0.07%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.